SeqLL Inc. Stock price

Equities

SEQL

US81734C3043

Advanced Medical Equipment & Technology

Market Closed - OTC Markets 01:25:44 2024-03-27 pm EDT 5-day change 1st Jan Change
2.99 USD -0.33% Intraday chart for SeqLL Inc. -6.56% -27.60%
Sales 2021 210K Sales 2022 78.66K Capitalization 3.46M
Net income 2021 -3M Net income 2022 -4M EV / Sales 2021 65 x
Net cash position 2021 8.57M Net cash position 2022 3.29M EV / Sales 2022 2.14 x
P/E ratio 2021
-3.64 x
P/E ratio 2022
-0.84 x
Employees 7
Yield 2021 *
-
Yield 2022
-
Free-Float 56.24%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.33%
1 week-6.56%
Current month-14.57%
1 month-21.32%
3 months-29.65%
6 months-82.50%
Current year-27.60%
More quotes
1 week
2.99
Extreme 2.99
3.15
1 month
2.99
Extreme 2.99
3.75
Current year
2.99
Extreme 2.99
5.09
1 year
2.99
Extreme 2.99
35.36
3 years
2.99
Extreme 2.99
232.00
5 years
2.99
Extreme 2.99
232.00
10 years
2.99
Extreme 2.99
232.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 44 12-12-31
Director of Finance/CFO 57 22-08-08
Chief Tech/Sci/R&D Officer 43 14-04-30
Members of the board TitleAgeSince
Director/Board Member 63 -
Director/Board Member 65 21-08-30
Chief Executive Officer 44 12-12-31
More insiders
Date Price Change Volume
24-03-27 2.99 -0.33% 831
24-03-26 3 -6.25% 1,223

Delayed Quote OTC Markets, March 27, 2024 at 01:25 pm EDT

More quotes
SeqLL Inc. (SeqLL) is a life sciences instrumentation and research services company that is engaged in the development of scientific assets and intellectual property across multiple omics fields. The Company is engaged in the design, development and manufacturing of genetic analysis technologies. It leverages its True Single Molecule Sequencing (tSMS) technology, which enables researchers and clinicians to contribute advancements to scientific research and development. Its tSMS platform offers a single molecule solution for deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) sequencing by performing detection of nucleic acids without the need for complex sample manipulation. Researchers using its platform can analyze billions of single molecules in a single experiment and generate reproducible data. Its single molecule platform combines a fluorescence-based optical detection apparatus with a precision microfluidics and thermal control system to perform sequencing-by-synthesis.
More about the company
  1. Stock
  2. Equities
  3. Stock SeqLL Inc. - OTC Markets